Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Cash: 2013-2024

Historic Change in Cash for Collegium Pharmaceutical (COLL) over the last 12 years, with Dec 2024 value amounting to -$143.4 million.

  • Collegium Pharmaceutical's Change in Cash rose 130.07% to $32.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.0 million, marking a year-over-year increase of 154.47%. This contributed to the annual value of -$143.4 million for FY2024, which is 324.88% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Change in Cash stood at -$143.4 million for FY2024, which was down 324.88% from $63.8 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Change in Cash ranged from a high of $63.8 million in FY2023 and a low of -$143.4 million during FY2024.
  • Moreover, its 3-year median value for Change in Cash was -$12.7 million (2022), whereas its average is -$30.8 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Change in Cash spiked by 600.54% in 2023, and later slumped by 324.88% in 2024.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's Change in Cash stood at $6.6 million in 2020, then soared by 85.28% to $12.3 million in 2021, then slumped by 203.48% to -$12.7 million in 2022, then spiked by 600.54% to $63.8 million in 2023, then tumbled by 324.88% to -$143.4 million in 2024.